Methadone Clinics in Louisiana

Methadone clinics in Louisiana offer affordable, convenient and effective medication assisted treatment for opiate dependence. Users get the medical intervention they need to get sober and stay that way.

Methadone Clinics in cities of Louisiana

Finding Opioid Use Disorder Treatment Across Louisiana

Louisiana treats opioid use disorder with the same three FDA-approved medications available nationwide, but where you can get them varies a lot by parish. The larger metros, New Orleans, Baton Rouge, Shreveport, Lafayette, and Lake Charles, have opioid treatment programs and office-based prescribers, while many rural parishes have no nearby clinic and lean on telehealth and take-home dosing to close the gap.

Medications for opioid use disorder (MOUD) include methadone, buprenorphine (including Suboxone), and naltrexone (including Vivitrol). The listings on this page connect you to providers in your area, and the helpline is there if you would rather talk it through first.

The Three Medications and Where Each One Is Available

Opioid use disorder is a treatable medical condition, and three medications are the standard of care. Methadone is a full opioid agonist that steadies withdrawal and cravings. For opioid use disorder, it is provided only through a licensed opioid treatment program (OTP), not a regular pharmacy.

Buprenorphine, including Suboxone and other buprenorphine-naloxone products, is a partial agonist with a built-in ceiling that lowers overdose risk; it can be prescribed in a doctor’s office and filled at a pharmacy, or provided through a clinic. Extended-release injectable buprenorphine, such as Sublocade, is a once-monthly shot.

Naltrexone, including the monthly Vivitrol injection, blocks opioids rather than activating them, and any licensed provider can prescribe it, though treatment starts only after a person has stopped using opioids for a set time to avoid sudden withdrawal.

Those medications reach you through two settings. Opioid treatment programs handle methadone and often buprenorphine, with dosing on-site early on. Office-based opioid treatment (OBOT) means a physician, nurse practitioner, or physician assistant manages buprenorphine or naltrexone in a regular medical office, with prescriptions filled at your pharmacy.

If you are weighing the options, it helps to see how methadone and Suboxone compare and to read up on how methadone treatment actually works before you call. Which medication fits is a decision to make with a clinician, not something to settle from a web page.

State Rules, Coverage, and Funding in Louisiana

Louisiana Medicaid, delivered through the Healthy Louisiana managed care plans, covers all three medications for opioid use disorder, including methadone dispensed through opioid treatment programs, which the state added as a covered OTP benefit in 2020.

In January 2026, the state made its MOUD benefit permanent under its Medicaid State Plan. Some buprenorphine products carry prior authorization, so it is worth confirming specifics with a provider or your plan.

A 2019 state law, Act 425, went further than most states by requiring licensed residential treatment facilities to offer buprenorphine and naltrexone on-site, and a Pew analysis found MOUD use among Louisiana Medicaid enrollees with opioid use disorder more than tripled from 2018 to 2021.

The State Opioid Treatment Authority, housed in the Louisiana Department of Health’s Office of Behavioral Health, oversees the OTPs. Under federal rules updated in 2024, programs can approve take-home methadone on a graduated schedule as a patient stabilizes, up to a 28-day supply, with eligibility decided by the program. Louisiana’s own OTP manual mirrors that graduated approach and requires methadone admission visits to happen in person rather than by telehealth.

Buprenorphine, by contrast, can be started through telehealth, including by phone in many cases, without a prior in-person visit; those federal flexibilities run through 2026 and are still being finalized, so confirm what is current when you call.

Naloxone is available across the state without a personal prescription under a standing order from the Louisiana Department of Health, and the state’s Good Samaritan law protects people who call for help during an overdose. For patients balancing work and treatment, it can help to understand how treatment and employment fit together and why a steady dose matters.

Louisiana’s Overdose Picture Is Improving

The numbers are moving in the right direction. Louisiana recorded about 1,700 drug-involved deaths in 2024, down from 2,456 in 2023, the lowest total since 2020, according to the Louisiana Opioid Surveillance Program data presented to the state’s Opioid Abatement Task Force in December 2025.

Deaths involving synthetic opioids like fentanyl fell about 35 percent over that year. Fentanyl still dominates the drug supply, though: of the deceased Louisianans tested in 2024, 50.8 percent were positive for fentanyl. The gains are also uneven. State epidemiologists noted that 23 parishes, many of them rural, including Claiborne, Caldwell, and Tensas, now have age-adjusted drug-death rates above the statewide rate of 36 per 100,000.

Wherever you are in the state, effective medication treatment exists, and the providers listed on this page are a place to start. You can also read more about opioid use disorder and how it develops.

How to Start Treatment in Louisiana

Starting treatment usually begins with an intake assessment, where a provider reviews your history and recommends a medication and setting. Bring an ID and any insurance or Medicaid information if you have it. If you do not, ask about self-pay or sliding-scale options, since many programs offer them.

One statewide resource worth knowing is the Louisiana Bridge Program (LA Bridge), an Office of Behavioral Health and Office of Public Health partnership modeled on the California Bridge program that starts MOUD in participating hospital emergency departments and links people to ongoing outpatient care.

If you are coming off fentanyl, the timing of a first buprenorphine dose matters, because starting too soon can trigger sudden, severe withdrawal (called precipitated withdrawal), so a clinician will plan that first dose with you. For a closer look at that step, see our guide to treatment when fentanyl is involved and the broader overview of opioid use disorder treatment. Use the listings above to find a provider near you, or call the helpline.

Pregnancy, Parenting, and Justice-Involved Care

Some situations call for extra coordination. For pregnant patients, continuing methadone or buprenorphine is the recommended standard of care, and stopping suddenly can be dangerous for both parent and baby. Providers plan for neonatal opioid withdrawal syndrome (NOWS), which is expected and manageable.

Fear of losing custody keeps some pregnant people from seeking care, but treatment is the protective choice, and Louisiana’s Project M.O.M. (Maternal Overdose Mortality), a Department of Health initiative, embeds perinatal navigators in hospitals to keep MOUD going across prenatal, delivery, and postpartum care.

Medication treatment is also compatible with drug court, probation, and reentry requirements, and providers can often document participation when a court or program requires it. Families supporting a loved one can start with our page on how to help someone in treatment and information on methadone and pregnancy.

Common Questions About Treatment in Louisiana

Does Louisiana Medicaid pay for methadone and Suboxone?

Yes, Healthy Louisiana Medicaid plans cover all three FDA-approved medications, including methadone through opioid treatment programs and buprenorphine and naltrexone. Some buprenorphine products need prior authorization, so confirm the details with your plan or provider.

Can I start buprenorphine by telehealth in Louisiana?

In many cases, yes. Federal rules currently allow buprenorphine to be started through telehealth, including by phone, without a prior in-person visit. These flexibilities run through 2026 and are still being finalized, so ask a provider what applies now. Methadone admission visits in Louisiana must happen in person.

Do I have to go to a clinic every day for methadone?

At first, usually yes. As you stabilize, federal rules updated in 2024 let programs approve take-home methadone on a graduated schedule, up to a 28-day supply. Eligibility is decided by your program based on your progress. You can read more about how methadone works long term.

How much does treatment cost without insurance?

It varies by provider and medication. Many opioid treatment programs and office-based prescribers offer sliding-scale fees or self-pay rates, and federal block grant funds support some care for people without coverage. Ask each provider directly, since costs are not standardized.

Is a monthly injection an option instead of daily pills?

For some people. Extended-release buprenorphine (Sublocade) is a monthly injection, and naltrexone (Vivitrol) is also given monthly after a person has fully stopped opioids. Whether either fits depends on your situation and is decided with a clinician.

Page Details and Disclosures

Last reviewed July 2026.

Sources:

Louisiana Opioid Surveillance Program, Surveillance Update presented to the Louisiana Opioid Abatement Task Force, December 2025. https://ldh.la.gov/assets/OPH/Center-PHI/LaOTF_Surveillance_Update_Dec2025.pdf
Louisiana Department of Health, Office of Behavioral Health, State Opioid Treatment Authority; Louisiana Bridge Program; Project M.O.M.; Naloxone Standing Order (La. R.S. 40:978.2). https://law.justia.com/codes/louisiana/revised-statutes/title-40/rs-40-978-2/
Louisiana Healthcare Connections, Opioid Treatment Program manual revisions, 2025. https://www.louisianahealthconnect.com/newsroom/notice-of-manual-revisions-regarding-opioid-treatment-programs.html
Centers for Medicare and Medicaid Services, Louisiana State Plan Amendment LA-25-0020, approved January 2026. https://www.medicaid.gov/medicaid/spa/downloads/LA-25-0020.pdf
The Pew Charitable Trusts, Louisiana MOUD reform analysis, 2024. https://www.pew.org/en/research-and-analysis/articles/2024/02/26/louisiana-reforms-connect-medicaid-enrollees-to-lifesaving-addiction-treatment
SAMHSA and DEA, 42 CFR Part 8 (2024) and buprenorphine telemedicine rules, 2025 to 2026. https://www.samhsa.gov/substance-use/treatment/opioid-treatment-program/42-cfr-part-8

MethadoneCenters.com is a referral service that provides information about addiction treatment providers and facilities. It is not a medical provider or treatment facility and does not provide medical advice, endorse any facility, or guarantee the quality of care or results of any provider. The information here is not a substitute for professional medical advice.

Calls to any general helpline may be answered by a paid advertiser. We do not receive a commission or fee that depends on which provider a caller chooses, and there is no obligation to enter treatment. To reach non-sponsor programs, you can browse the listings on this site or visit SAMHSA at samhsa.gov/find-help.